Thomas P. Segerson
About
In The Last Decade
Thomas P. Segerson
25 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 99
- Cellular and Molecular Neuroscience 1.3k
- Endocrinology, Diabetes and Metabolism 874
- Molecular Biology 722
- Psychiatry and Mental health 645
- Sensory Systems 331
Countries citing papers authored by Thomas P. Segerson
This map shows the geographic impact of Thomas P. Segerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Segerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Segerson more than expected).
Fields of papers citing papers by Thomas P. Segerson
This network shows the impact of papers produced by Thomas P. Segerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Segerson. The network helps show where Thomas P. Segerson may publish in the future.
Co-authorship network of co-authors of Thomas P. Segerson
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Segerson. A scholar is included among the top collaborators of Thomas P. Segerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Segerson. Thomas P. Segerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 21 | |
| 3 | 114 | |
| 4 | 15 | |
| 5 | Breakthroughs in Andrology Vardenafil for Treatment of Men With Erectile Dysfunction: Efficacy and Safety in a Randomized, Double-Blind, Placebo-Controlled Trial | 2 |
| 6 | 239 | |
| 7 | 174 | |
| 8 | 31 | |
| 9 | 1 | |
| 10 | 31 | |
| 11 | 125 | |
| 12 | 224 | |
| 13 | 79 | |
| 14 | 214 | |
| 15 | 40 | |
| 16 | 65 | |
| 17 | 54 | |
| 18 | 107 | |
| 19 | 277 | |
| 20 | 150 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.